Novartis researchers aim to improve the lives of patients with osteoarthritis.

We’re working to bring the hope of advanced medicine to more patients.

Targeting inflammation to fight cancer is a new approach with a long history.

A conversation with Novartis Chief Digital Officer Bertrand Bodson

Molecular glues are a new type of medicine inspired by nature’s matchmakers.

Novartis data scientists are using super-resolution microscopy to see neurodegeneration the moment it starts.

Novartis researchers are working to extend the life of organ transplants

Combination of two compounds shows promise in the lab

A new type of medicine that targets RNA was discovered by accident and could change the way some diseases are treated.

Phil Gotwals talks about his vision for the future of business development for research.

Novartis investigators find genetic explanations for why some young patients relapse.

Researchers from industry and academia will leverage new chemistry to hit difficult drug targets.